Christopher J. Gerry

Christopher J. Gerry

Auto-generated profile, based on publicly available information

Christopher J. Gerry

Chemical Biology and Therapeutics Science Program, Broad Institute, Cambridge, USA

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 April 2018 in Nature Reviews Drug Discovery
Verified
Journal Article
Closed access
PDF file
CGChristopher J. Gerry
Christopher J. Gerry
SSStuart L. Schreiber
Stuart L. Schreiber

20 March 2020 in Nature Chemical Biology
Verified
Journal Article
Closed access
PDF file
CGChristopher J. Gerry
Christopher J. Gerry
SSStuart L. Schreiber
Stuart L. Schreiber

8 September 2014 in ACS Chemical Biology
Verified
Journal Article
Open access
TDTony Davis
Tony Davis
CGChristopher J. Gerry
Christopher J. Gerry
DTDerek S. Tan
Derek S. Tan
The chemical features that impact small-molecule permeability across bacterial membranes are poorly understood, and the resulting lack of tools to predict permeability presents a major obstacle to the discovery and development of novel antibiotics. Antibacterials are known to have vastly different structural and physicochemical properties compared to nonantiinfective drugs, as illustrated herein by principal component analysis (PCA). To understand how these properties influence bacterial permeability, we have developed a systematic approach to evaluate the penetration of diverse compounds into bacteria with distinct cellular envelopes. Intracellular compound accumulation is quantitated using LC-MS/MS, then PCA and Pearson pairwise correlations are used to identify structural and physicochemical parameters that correlate with accumulation. An initial study using 10 sulfonyladenosines in Escherichia coli, Bacillus subtilis, and Mycobacterium smegmatis has identified nonobvious correlations between chemical structure and permeability that differ among the various bacteria. Effects of cotreatment with efflux pump inhibitors were also investigated. This sets the stage for use of this platform in larger prospective analyses of diverse chemotypes to identify global relationships between chemical structure and bacterial permeability that would enable the development of predictive tools to accelerate antibiotic drug discovery.

11 June 2019 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
CGChristopher J. Gerry
Christopher J. Gerry
MWMathias J. Wawer
Mathias J. Wawer
PCPaul A. Clemons
Paul A. Clemons
SSStuart L. Schreiber
Stuart L. Schreiber

1 June 2020 in Current Opinion in Chemical Biology
Verified
Journal Article
Closed access
CGChristopher J Gerry
Christopher J Gerry
SSStuart L Schreiber
Stuart L Schreiber

14 February 2019 in Organic Letters
Verified
Journal Article
Closed access
CGChristopher J. Gerry
Christopher J. Gerry
ZYZhenhua Yang
Zhenhua Yang
MSMichele Stasi
Michele Stasi
SSStuart L. Schreiber
Stuart L. Schreiber